ABBV-525
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-525, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets [Phase 1]